Md. Negligence Doctrine Gives Takeda Win In Actos Suit
Takeda Pharmaceuticals USA Inc. on Thursday dodged a potential $1.8 million jury award in a suit over its diabetes drug Actos because the Maryland jury also found that the plaintiff had...To view the full article, register now.
Already a subscriber? Click here to view full article